Lung Neoplasms

"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the LUNG.

Descriptor ID	D008175
MeSH Number(s)	C04.588.894.797.520 C08.381.540 C08.785.520
Concept/Terms	Lung Neoplasms Lung Neoplasms Pulmonary Neoplasms Neoplasms, Lung Lung Neoplasm Neoplasm, Lung Neoplasms, Pulmonary Neoplasm, Pulmonary Pulmonary Neoplasm Lung Cancer Lung Cancer Cancer, Lung Cancers, Lung Lung Cancers Pulmonary Cancer Cancer, Pulmonary Cancers, Pulmonary Pulmonary Cancers Cancer of the Lung Cancer of Lung

Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Thoracic Neoplasms [C04.588.894]
Respiratory Tract Neoplasms [C04.588.894.797]
Lung Neoplasms [C04.588.894.797.520]
Respiratory Tract Diseases [C08]
Lung Diseases [C08.381]
Lung Neoplasms [C08.381.540]
Respiratory Tract Neoplasms [C08.785]
Lung Neoplasms [C08.785.520]

Below are MeSH descriptors whose meaning is related to "Lung Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.

Bar chart showing 4790 publications over 31 distinct years, with a maximum of 259 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	39	10	49
1993	36	11	47
1994	44	11	55
1995	54	18	72
1996	61	20	81
1997	57	22	79
1998	52	24	76
1999	63	21	84
2000	87	26	113
2001	72	29	101
2002	106	26	132
2003	122	29	151
2004	116	42	158
2005	125	37	162
2006	125	23	148
2007	144	37	181
2008	159	34	193
2009	131	35	166
2010	164	38	202
2011	202	35	237
2012	203	35	238
2013	205	35	240
2014	207	26	233
2015	210	26	236
2016	225	25	250
2017	203	33	236
2018	227	32	259
2019	202	20	222
2020	234	20	254
2021	130	4	134
2022	1	0	1

Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.

Wilson AN, Chen B, Liu X, Kurie JM, Kim J. A Method for Orthotopic Transplantation of Lung Cancer in Mice. Methods Mol Biol. 2022; 2374:231-242.

View in: PubMed
Tang M, Abbas HA, Negrao MV, Ramineni M, Hu X, Hubert SM, Fujimoto J, Reuben A, Varghese S, Zhang J, Li J, Chow CW, Mao X, Song X, Lee WC, Wu J, Little L, Gumbs C, Behrens C, Moran C, Weissferdt A, Lee JJ, Sepesi B, Swisher S, Cheng C, Kurie J, Gibbons D, Heymach JV, Wistuba II, Futreal PA, Kalhor N, Zhang J. The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics. Nat Commun. 2021 12 06; 12(1):7081.

View in: PubMed
Polites SF, Heaton TE, LaQuaglia MP, Kim ES, Barry WE, Goodhue CJ, Murphy AJ, Davidoff AM, Langham MR, Meyers RL, Short SS, Lautz TB, Glick RD, Vasudevan SA, Bence CM, Lal DR, Baertschiger RM, Emr B, Malek MM, Dasgupta R. Pneumonectomy for Pediatric Tumors-a Pediatric Surgical Oncology Research Collaborative Study. Ann Surg. 2021 12 01; 274(6):e605-e609.

View in: PubMed
Hinterleitner C, Strähle J, Malenke E, Hinterleitner M, Henning M, Seehawer M, Bilich T, Heitmann J, Lutz M, Mattern S, Scheuermann S, Horger M, Maurer S, Walz J, Fend F, Handgretinger R, Seitz C, Weigelin B, Singer S, Salih H, Borst O, Kopp HG, Zender L. Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer. Nat Commun. 2021 12 01; 12(1):7005.

View in: PubMed
Chang JY, Verma V, Feng L, Roth JA. SABR for operable stage I non-small-cell lung cancer: comparison to surgery - Authors' reply. Lancet Oncol. 2021 12; 22(12):e537-e538.

View in: PubMed
Chen M, Chen R, Jin Y, Li J, Hu X, Zhang J, Fujimoto J, Hubert SM, Gay CM, Zhu B, Tian Y, McGranahan N, Lee WC, George J, Hu X, Chen Y, Wu M, Behrens C, Chow CW, Pham HHN, Fukuoka J, Wu J, Parra ER, Little LD, Gumbs C, Song X, Wu CJ, Diao L, Wang Q, Cardnell R, Zhang J, Wang J, Le X, Gibbons DL, Heymach JV, Jack Lee J, William WN, Cheng C, Glisson B, Wistuba I, Andrew Futreal P, Thomas RK, Reuben A, Byers LA, Zhang J. Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer. Nat Commun. 2021 11 17; 12(1):6655.

View in: PubMed
Eyestone E, Williams RM, Luta G, Kim E, Toll BA, Rojewski A, Neil J, Cinciripini PM, Cordon M, Foley K, Haas JS, Joseph AM, Minnix JA, Ostroff JS, Park E, Rigotti N, Sorgen L, Taylor KL. Predictors of Enrollment of Older Smokers in Six Smoking Cessation Trials in the Lung Cancer Screening Setting: The Smoking Cessation at Lung Examination (SCALE) Collaboration. Nicotine Tob Res. 2021 11 05; 23(12):2037-2046.

View in: PubMed
Banerjee P, Xiao GY, Tan X, Zheng VJ, Shi L, Rabassedas MNB, Guo HF, Liu X, Yu J, Diao L, Wang J, Russell WK, Roszik J, Creighton CJ, Kurie JM. The EMT activator ZEB1 accelerates endosomal trafficking to establish a polarity axis in lung adenocarcinoma cells. Nat Commun. 2021 11 03; 12(1):6354.

View in: PubMed
Malek AE, Khalil M, Hachem R, Chaftari AM, Fares J, Jiang Y, Kontoyiannis DP, Fossella F, Chaftari P, Mulanovich VE, Viola GM, Raad II. Impact of Checkpoint Inhibitor Immunotherapy, Primarily Pembrolizumab, on Infection Risk in Patients With Advanced Lung Cancer: A Comparative Retrospective Cohort Study. Clin Infect Dis. 2021 11 02; 73(9):e2697-e2704.

View in: PubMed
Ramagopalan S, Gupta A, Arora P, Thorlund K, Ray J, Subbiah V. Comparative Effectiveness of Atezolizumab, Nivolumab, and Docetaxel in Patients With Previously Treated Non-Small Cell Lung Cancer. JAMA Netw Open. 2021 11 01; 4(11):e2134299.

View in: PubMed

People

Explore

Similar Concepts

Top Journals